Is It Ethical Conducting Placebo-Controlled Clinical Trials as Part of the Development of New Drugs for the Treatment of Major Depressive Disorder? (And II). Benefit/risk Ratio and Informed Consent. Conclusions
Medicina Clinica 2004 October 30; 123(15): 585-590
Showing items related by title, author, creator and subject.
Is it ethical conducting placebo-controlled clinical trials as part of the development of new drugs for the treatment of major depressive disorder? (I). Considerations on the value and scientific validity of the study Gracia, Diego; Lahuerta, Juan; Carné, Xavier; Dal-Ré, Rafael (2004-10-30)
Suicide Risk in Placebo-Controlled Trials of Treatment for Acute Manic Episode and Prevention of Manic-Depressive Episode Storosum, Jitschak G.; Wohlfarth, Tamar; Gispen-de Wied, Christine C.; Linszen, Don H.; Gersons, Berthold P.R.; van Zwieten, Barbara J.; van den Brink, Wim (2005-04)
The Use of Placebo-Controlled Clinical Trials for the Approval of Psychiatric Drugs: Part II-Ethical Considerations Related to the Individual Participant Feifel, David (2009-12)This is Part 2 of a two-part series on the ethical issues surrounding the use of placebo arms in clinical trials for psychiatric drugs. Part 1 discussed the ethical argument from a statistical, population-based perspective. ...